Free Confidential Online Consultation
Board-certified Physicians, trusted medications
Fast, free shipping1
Fill in a brief health assessment form, 100% online
Zepbound
Zepbound
Zepbound® (tirzepatide injection) is the newest FDA-approved GLP-1 medication, targeting both GLP-1 and GIP to help you achieve your weight loss and health goals.
For $99/mo, our comprehensive program includes virtual provider visits, personalized health coaching, lab access, and continuous support. Medication not included.
ZEPBOUND
As low as
- 0%
Sold out
Regular price
$99.00
PER MONTH
Regular price
Sale price
$99.00
Unit price
per
Couldn't load pickup availability
100% Online!
US board-certified doctors
Fast Shipping
Start Your Zepbound® Prescription Online
Your TrulyRx membership covers the doctor visit and pharmacy prescription. Medication ships directly from and is billed by LillyDirect.
The 5 Easy Steps to get Zepbound from TrulyRx
1. Click “Add To Cart” below and complete the checkout.
2. Join the TrulyRx Membership for Weight Loss— pay $99 per month for ongoing care.
3. The TrulyRx medical team reviews your info within 24 hours and, if approved, e-prescribes Zepbound from LillyDirect.
4. LillyDirect contacts you for payment ($349 per month for 2.5 mg; $499 for higher doses) and ships your medication.
5. All Zepbound is sold, billed, and shipped exclusively by LillyDirect.
Get Lean, Stay Mean
Tired of fighting a losing battle? Zepbound® has your back—helping you take charge of your body and goals.
- Shreds stubborn fat
- Helps lower BMI
- Regulates insulin levels
- Supports lower blood pressure
- Trims waistline
Get prescription medications tailored for you in 3 easy steps
2
Our board-certified physicians will review your answers and determine if a prescription is right for you
3
Fast, free delivery if granted a prescription
Frequently Asked Questions
Zepbound uses the same active ingredient (tirzepatide) as Mounjaro®. It’s a dual-action GLP-1/GIP-receptor agonist that is approved by the FDA for people with obesity, or overweight plus a weight-related condition, along with diet and exercise changes.
Zepbound and Wegovy are approved by the FDA for weight loss, while Ozempic is approved for the treatment of type 2 diabetes, but can be prescribed off-label for weight loss, if appropriate.
The main difference between these medications is the active ingredient. Ozempic and Wegovy use semaglutide, while Zepbound uses tirzepatide. Tirzepatide is a dual-action GLP-1 and GIP, meaning it works by activating two receptors to curb nausea and regulate your metabolism, helping you feel full faster and longer. In comparison, semaglutide only activates the GLP-1 receptor.
